MedPath

A study for evaluating the effect of food containing lactic acid bacteria on relating nasal and ocular symptoms.

Not Applicable
Conditions
Healthy adult
Registration Number
JPRN-UMIN000037571
Lead Sponsor
TTC Co., Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

(1)Subjects who routinely take food or medicine containing lactic acid bacteria or natto bacteria. (2)Subjects who have severe nasal and eye symptoms affecting judgement of discomfort. (3)Subjects who routinely take medicines affecting the test result. (4)Subjects who are under medication (specific desensitization therapy) which may influence the outcome of the study. (5)Subjects who are engaged in drive a car or operate a hazardous machine. (6)Subjects judged as unsuitable for the stuzy by the investigator for laboratory evidence or cardiopulmonary function. (7)Subjects who have a disease requiring regular medication or a history of serious disease for which medication was required. (8)Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination on preliminary examination. (9)Subjects who are liable to cause an allergy related to the study. (10)Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire. (11)Subjects who have participated in other clinical study within the last one month prior to the current study or are planned to participate in other clinical study after informed consent for the current study. (12)Subjects who are planned to become pregnant after informed consent for the current study or are pregnant or lactating. (13)Subjects who are judged as unsuitable for the study by the investigator for other reason.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Subject's nasal or ocular symptom in an environmental exposure unit(EEU). (the number of sneezes and nose blowing, eye itching, watery eyes)
Secondary Outcome Measures
NameTimeMethod
1.Visual analog scale(EEU) (nasal blockage, nasal itching, throat symptoms, sleepiness, disturbance of daily living) 2.Visual analog scale(after exposure Japanese cedar pollen) (the number of sneezes and nose blowing, nasal blockage, nasal itching, eye itching, watery eyes, throat symptoms, sleepiness, disturbance of daily living) 3.QOL questionnaire, diagnosis subject's noses, eosinophil of nasal mucus and skin questionnaire.
© Copyright 2025. All Rights Reserved by MedPath